We are live on ! Find out more
SPS

Susquehanna Portfolio Strategies Portfolio holdings

AUM $6.73B
1-Year Est. Return 45.57%
This Fund
S&P 500
This Quarter Est. Return
+9.25%
1 Year Est. Return
+45.57%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.58B
AUM Growth
+$4.35B
Cap. Flow
+$4.06B
Cap. Flow %
88.65%
Top 10 Hldgs %
12.71%
Holding
855
New
695
Increased
118
Reduced
12
Closed
24

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$63.7M
2
PFE icon
Pfizer
PFE
+$63.5M
3
EQIX icon
Equinix
EQIX
+$55.4M
4
SBUX icon
Starbucks
SBUX
+$54.1M
5
AAPL icon
Apple
AAPL
+$54M

Top Sells

Rank Stock Value
1
MFC icon
Manulife Financial
MFC
+$7.89M
2
PCG icon
PG&E
PCG
+$5.39M
3
BX icon
Blackstone
BX
+$3.1M
4
JWN
Nordstrom
JWN
+$2.04M
5
ACI icon
Albertsons Companies
ACI
+$1.94M

Sector Composition

Rank Sector Weight
1 Technology 17.19%
2 Financials 16.3%
3 Healthcare 13.62%
4 Consumer Discretionary 12.99%
5 Industrials 11.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DAN icon
801
Dana Inc
DAN
$3.2B
$185K ﹤0.01%
+10,778
New +$161K
RYAM icon
802
Rayonier Advanced Materials
RYAM
$561M
$184K ﹤0.01%
+47,748
New +$201K
CCCC icon
803
C4 Therapeutics
CCCC
$480M
$181K ﹤0.01%
+126,900
New +$185K
SPWH icon
804
Sportsman's Warehouse
SPWH
$46M
$174K ﹤0.01%
+50,455
New +$113K
SPIR icon
805
Spire Global
SPIR
$571M
$169K ﹤0.01%
+14,176
New +$143K
ALLT icon
806
Allot
ALLT
$377M
$160K ﹤0.01%
+18,753
New +$135K
SGHC icon
807
SGHC Ltd
SGHC
$6.51B
$159K ﹤0.01%
+14,500
New +$123K
VERV
808
DELISTED
Verve Therapeutics
VERV
$149K ﹤0.01%
+13,300
New +$75.8K
BDTX icon
809
Black Diamond Therapeutics
BDTX
$121M
$142K ﹤0.01%
+57,143
New +$110K
LUNG icon
810
Pulmonx
LUNG
$98.4M
$139K ﹤0.01%
+53,526
New +$211K
EVGO icon
811
EVgo
EVGO
$497M
$131K ﹤0.01%
+35,883
New +$123K
PVBC
812
DELISTED
Provident Bancorp
PVBC
$127K ﹤0.01%
+10,155
New +$115K
BORR
813
Borr Drilling
BORR
$1.27B
$124K ﹤0.01%
+68,030
New +$129K
RBBN icon
814
Ribbon Communications
RBBN
$372M
$121K ﹤0.01%
+30,173
New +$109K
ADCT icon
815
ADC Therapeutics
ADCT
$156M
$116K ﹤0.01%
+43,426
New +$91.3K
AIP icon
816
Arteris
AIP
$1.39B
$112K ﹤0.01%
+11,775
New +$86.8K
GROY icon
817
Gold Royalty Corp
GROY
$732M
$111K ﹤0.01%
+50,203
New +$88.1K
LAZR
818
DELISTED
Luminar Technologies
LAZR
$97.4K ﹤0.01%
+33,937
New +$129K
ATXS
819
DELISTED
Astria Therapeutics
ATXS
$95.9K ﹤0.01%
+17,900
New +$86.8K
ORGO icon
820
Organogenesis Holdings
ORGO
$233M
$92.6K ﹤0.01%
+25,294
New +$94.3K
DOUG icon
821
Douglas Elliman
DOUG
$184M
$91.9K ﹤0.01%
+39,603
New +$84.6K
SVRA icon
822
Savara
SVRA
$1.17B
$90.8K ﹤0.01%
+39,839
New +$108K
LXEO icon
823
Lexeo Therapeutics
LXEO
$400M
$89.5K ﹤0.01%
+22,259
New +$73.2K
NGL icon
824
NGL Energy Partners
NGL
$2.12B
$84.6K ﹤0.01%
+19,813
New +$71K
RERE
825
ATRenew
RERE
$988M
$83.9K ﹤0.01%
+25,346
New +$65.9K
31 32
33
34 35

Similar funds

SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
CIMLRA
CBRE Investment Management Listed Real Assets Radnor, Pennsylvania $6.75B AUM 8.88% 1-Year Est. Return
JCAM
Jericho Capital Asset Management New York $6.76B AUM 88.1% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 28.97% 1-Year Est. Return
AG
Algert Global San Francisco, California $6.65B AUM 53.68% 1-Year Est. Return
GAM
Groupama Asset Management Paris, France $6.85B AUM 43.37% 1-Year Est. Return
HFS
Hantz Financial Services Southfield, Michigan $6.56B AUM 16.11% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return

Susquehanna Portfolio Strategies's Q2 2025 Portfolio in Review

As of Q2 2025, Susquehanna Portfolio Strategies held 855 positions worth $4.58B, up 1,869% from $233M the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Susquehanna Portfolio Strategies deployed $4.06B of net new capital in Q2 2025, opening 695 new positions and adding to 118 existing holdings. Its largest new stake was Merck: 800,753 shares worth $63.4M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 9% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Manulife Financial, an estimated $7.89M trimmed.

  • Susquehanna Portfolio Strategies's largest Q2 2025 buy was Merck: 800,753 shares worth $63.4M.
  • Susquehanna Portfolio Strategies added most to Blackrock in Q2 2025, an estimated $53.7M increase.
  • Susquehanna Portfolio Strategies's biggest Q2 2025 reduction was Manulife Financial, cutting an estimated $7.89M.
  • Susquehanna Portfolio Strategies fully exited Blackstone in Q2 2025, selling an estimated $3.1M.
  • Susquehanna Portfolio Strategies's ten largest holdings make up 13% of its $4.58B portfolio in Q2 2025.
  • Susquehanna Portfolio Strategies opened 695 new positions and closed 24 in Q2 2025.
  • Susquehanna Portfolio Strategies's portfolio value rose 1,869% quarter-over-quarter to $4.58B.

Based on Susquehanna Portfolio Strategies's 13F filing for Q2 2025, filed 14 Aug 2025.